The current epidemic of childhood obesity will be a serious threat to population health for at least the next several decades. The biology of childhood obesity was the theme of an international symposium held in November 2007. Speakers discussed monogenic causes of obesity, prenatal epigenetic programing, neurobehavioral aspects of obesity, and hormonal and neuroendocrine abnormalities, and the insights provided by non-murine models for understanding the biology of early-onset obesity. Several new developments have been reported in white and brown adipose tissue biology. They are summarized briefly in this review and include observations about cell lineage of adipocytes, the renewal of adipocytes throughout life and the numerous factors that influence adipocyte fatty acid release. The biological underpinnings of childhood obesity are multiple and complex.
The current epidemic of childhood obesity is arguably the most important threat to the cardiovascular health of technologically-advanced countries in the 21st century. [1] [2] [3] Studies of the biology of obesity complement the important major public health initiatives aimed at increasing physical activity and improving food quality. 2 On 16 November 2007, the Merck Frosst/CIHR Research Chair on obesity at Université Laval held an international symposium on a multidisciplinary approach to understanding the complex biology of childhood obesity. Genetics, endocrinology, the intrauterine environment and epigenetic fetal programing, the neurochemistry and neurobehavioral aspects of obesity, and the interplay between the brain and the viscera, including intestine, liver, pancreas and adipose tissues, were each discussed. The symposium was paired with a second program on clinical, social and applied themes related to childhood obesity. The health impact of the childhood obesity epidemic was emphasized by all speakers. Early-onset obesity, a condition that is notoriously difficult to reverse, exposes the child to high levels of free fatty acids (FAs) and leptin, low adiponectin levels, and increases the risk of fatty liver, mechanical musculoskeletal stress and many other complications of obesity. During childhood, the level of danger is traditionally considered to be low, but children with obesity will carry the burden of an additional 10-20-year period of risk. Obesity at childhood can worsen during adulthood. The effects of exposure to these risk factors are generally similar in children and adults, although they are influenced by developmental stage.
The multiple determinants of the childhood obesity epidemic
Sadaf Farooqi set the stage by discussing the insidious nature of obesity at the population level. A minor increase in the average energy intake with respect to energy expenditure can shift a substantial fraction of the population into the obese category over the course of several years. Dr Farooqi also reviewed the physiology of obesity and the intricate physiological interactions among brain, gut, liver, pancreas and adipose tissue, with the extensive humoral and neurological cross-talk among these tissues (Figure 1) .
Monogenic inborn errors of metabolism leading to obesity serve as models that clearly show the biological importance of the mutant gene. Interestingly, these conditions primarily involve hormones or neurotransmitters and their hypothalamic receptors. Dr Farooqi presented several examples from her extensive experience. Leptin-deficient patients present severe obesity, and have a spectacular response to replacement therapy. Other conditions, such as MC4R deficiency, may produce a less severe degree of obesity, and affected individuals may be concealed within the general population of obese patients. Insulin, leptin and ghrelin each provides the brain with information on the body's energy status. Jean-Pierre Chanoine provided a stimulating review of prenatal and perinatal ghrelin metabolism, detailed elsewhere in this issue.
The usefulness of non-murine animal models was stressed by two speakers. Barry Levin shared some of his data in selectively bred diet-induced obese and obesity-resistant rats, both originally derived from the same outbred Sprague-Dawley colony. Many fascinating observations of the interactions among the genetics of the newborn rat, the genotype of the rearing mother and early exercise training in the determination of adult fat mass are described in his review in this issue.
The theme of Kevin Grove's presentation was the importance of non-human primate models for the study of obesity, the immense potential of such studies and the necessity of thoroughness in working with the precious materials derived from these long-term studies. His presentation included a discussion of many factors specific to primate studies and of his work on the effects of maternal high-fat diet on maternal, fetal and postnatal fat mass and energy metabolism.
The symposium was packed with information, and although some speakers addressed the effects of adipocytokines, time did not permit the discussion of adipose tissue biology. Some basic principles and recent highlights from this field are mentioned in the following paragraphs.
Concepts and developments in adipose tissue biology
White adipose tissue (WAT) is the principal target tissue in obesity. Obesity results from chronic imbalances between energy intake and expenditure, individual differences in energy metabolism, sympathetic innervation, 4 and adipose cell growth, proliferation and death. 5 Important parameters of WAT include cell number and triglyceride (TG) storage (measured by fat mass, adipocyte size, TG synthesis), anatomical location, adipocytokine secretion and lipolysis. Abdominal obesity is a major cardiovascular risk factor; 6 mesenteric WAT provides FAs directly to liver through the portal circulation, in which they can induce insulin resistance and result in high levels of hepatic insulin production. 7 Using an innovative technique involving the comparison of the known changes in environmental radioactivity over the past decades with the radioactivity measured in cellular DNA, the average age of adipocytes can be estimated. It has been shown recently that WAT adipocytes are renewed throughout life. 8 This is an important and decisive contribution to a decades-old debate about the origin and turnover of adipocytes. The biology of entry into adipogenesis and adipocyte death will have profound implications for the genesis, classification and treatment of obesity.
The cellularity of WAT is another important, related factor. It is known that pharmacological stimulation of the peroxisome proliferator-activated receptor-g (PPAR-g) pathway by thiazolidinedione drugs can induce abdominal obesity that is associated with an improvement in many cardiovascular risk factors. 9 In contrast with most forms of increased fat mass, in PPAR-g agonist-treated rodents 10 and humans, 9 the average size of WAT adipocytes is reduced compared with controls. Schematically, having a large number of small adipocytes is healthier than having a comparable or smaller volume of hypertrophied adipocytes. PPAR-g stimulation is felt to recruit new adipocytes from local stem cell populations. 9 There have also been several advances in brown adipose tissue (BAT) biology. BAT is the principal organ of nonshivering thermogenesis. After long being considered to be confined to rodents and human newborns and to be absent from healthy adults, BAT has been 'discovered' in adult humans, in different sites than in rodents, and may account for B20% of body glucose uptake during cold stress. 11 Thus,
BAT may potentially have a large impact on energy homeostasis in humans. Intuitively, BAT and WAT have been felt to be closely related to each other. Recent data suggest that BAT derives from the same lineage as skeletal muscle, distinct from the precursors of WAT, and that this fate change is related to the transcriptional regulator, PDRM16. 12 It will be interesting to note how this relates to the observations that cells with typical BAT morphology and characteristics develop within WAT depots under thermogenic stress (for example, Himms-Hagen et al.
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) or that WAT depots develop within smooth muscle when single developmental signaling pathways, such as Wnt, are disrupted. 14 
Other physiological changes in obesity
Obesity has wide-ranging consequences for WAT and other tissues. Adipocytes in WAT of obese subjects have decreased flux. The blood-brain barrier (BBB) excludes most FAs from the brain, and FAs are not major energy substrates for nervous tissue. However, the hypothalamus (HT) and some areas of the brain stem permit FA entry. These areas integrate information about peripheral levels of hormones and metabolites, and determine central nervous output to viscera in relation to this. LPL, lipoprotein lipase; TG, triglycerides; VLDL, very low-density lipoprotein.
mitochondrial activity, increased oxidative and endoplasmic reticulum (ER) stress, 15 inflammatory cytokine levels, macrophage infiltrates 5, 16 and increased necrotic death. 5 Elevated circulating FA levels are seen in obesity and are an independent cardiovascular risk factor. 17 
Hormone-sensitive lipase
Hormone-sensitive lipase is a cytoplasmic hydrolase that can cleave many FA esters (TG, DG, cholesteryl-and retinoic acid esters). 28 It is reversibly phosphorylated on multiple serine residues. The best-characterized phosphorylations are mediated by protein kinase A. 28 Cytoplasmic HSL is generally inactive. When activated by phosphorylation, it moves to the LDS. 29 HSL is rate limiting for DG, but not TG, hydrolysis; HSL-deficient WAT has an increased DG/TG ratio. 30 Hormone-sensitive lipase is essential for normal adipocyte morphology and function. In WAT, HSLÀ/À mice show adipocyte hypertrophy, reduced WAT mass, high inflammatory infiltrate, reduced adrenergic lipolysis but normal fasting lipolysis; in BAT they show marked hypertrophy, with development of univesicular adipocytes in interscapular BAT, sluggish glucose uptake but normal thermogenesis. 31 HSL also functions in several extra-adipose sites. 21, 32 The normal fasting lipolysis present in HSL deficiency 33 and even in mice in which all b-adrenergic receptors are absent, 34 illustrates the importance of HSL-and catecholamine-independent pathways of lipolysis. Hormone-sensitive lipase does not require a colipase, but the adipose fatty acid binding protein (FABP4, aP2) enhances HSL catalysis, presumably by binding FAs and reducing the free FA concentration locally. 35 A recent study suggests hypermetabolism in high-fat diet-fed HSL-deficient mice. 36 That particular HSLÀ/À strain differs from other HSLdeficient mice in WAT mass and insulin secretion 32, 37 for unexplained reasons, perhaps related to local conditions. It will be interesting to confirm this observation in other strains of HSL-deficient mice. Primary HSL deficiency has not been reported in humans. Other aspects of its phenotype in mice include male infertility 38 and cholesteryl ester storage in adrenal cortex 39 and HSL-deficient humans may be found among patients with one or more of these clinical features.
Adipose triglyceride lipase
Adipose triglyceride lipase is a major, recently described, partially characterized LDS lipase. 40 They have adipocyte hypertrophy, reduced fasting tolerance and cold intolerance, and die of lipid cardiomyopathy at about 12 weeks. Primary genetic defects have been described in humans, in whom ATGL mutations cause an adult-onset skeletal myopathy. 46, 47 The phenotypic difference with mice has not been explained. Some human mutations may retain partial activity, explaining the less serious phenotype. However, at least one patient with two apparently severe mutant alleles is reported to have presented with skeletal myopathy. 47 ATGLÀ/À mice have mild obesity and ATGLdeficient patients are not reported to have severe WAT pathology, although this has not been documented in detail. This is surprising if ATGL is essential for lipolysis. ATGL deficiency raises intriguing questions and is the key to understanding cytoplasmic TG metabolism. In mice, HSL and ATGL together can explain the great majority of adipocyte lipolysis; in WAT from ATGL-deficient mice, pharmacological inhibition of HSL reduces lipolysis to 2% of normal. 41 There is a debate regarding the relative importance of HSL and ATGL in mouse and human lipolysis. Recent data suggest that ATGL may play a lesser role in human than in rodent lipolysis 48 and may be more implicated in basal than in adrenergic-stimulated lipolysis. 22 
Control of lipolysis
Lipolytic control varies with species, age, sex and anatomical site. 49 The canonical pathway of lipolysis involves badrenergic action, which leads to a Gs protein-mediated increase in cyclic adenosine monophosphate, and the to phosphorylation and activation of HSL and perilipin. It is important not to neglect basal lipolysis, which although about 10-fold less than adrenergic-stimulated lipolysis, is constantly active and is felt to account for a major proportion of the FAs liberated during the day. Many signaling pathways are now implicated in mouse and human lipolysis. Several, but not all, involve G proteincoupled receptors. Although they vary with size, age and physiological demand, 'typical' human adipocytes, in contrast to rodent adipocytes, possess a2A adrenergic and natriuretic peptide receptors, but lack b3 adrenergic 50 and growth hormone 49, 51 responsiveness. Natriuretic peptides stimulate lipolysis by producing cyclic guanosine monophosphate, which results in phosphorylation and activation of HSL and perilipin; this pathway is considered to be important for exercise-induced lipolysis. 52 Tumor necrosis factor-a, produced by both adipocytes and by macrophages, stimulates lipolysis 53 in a b-adrenergic-independent fashion. Tumor necrosis factor-a treatment reduces the level of differentiation of adipocytes, reducing total perilipin but increasing the fraction of perilipin that is phosphorylated. b3-adrenergicstimulated lipolysis, in addition to stimulating the canonical Gs-mediated pathway, also activates a cyclic adenosine monophosphate-independent pathway involving Src kinase, mitogen-activated protein kinase kinase1/2 and extracellular signal-regulated kinase. 54 G protein-coupled receptors coupled to inhibitory G proteins suppress lipolysis. The most studied are a2A adrenergic receptors, the expression of which is intricately regulated. 49, 55, 56 Other inhibitory G-protein coupled receptor ligands are adenosine, 49 nicotinic acid and the ketone body, 3-hydroxybutyrate. Both of the latter ligands can bind the HM74a receptor in humans. 57 Basal, adrenergic and possibly inflammatory lipolyses are major considerations in understanding the body's FA balance. The physiological roles of the more recently described pathways are less defined. Pertinent to childhood obesity, the control of lipolysis varies at different ages. In neonates, thyrotropin is the main lipolytic hormone. 58 The adipocytes of young children have strong a-adrenergic sensitivity.
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The endoplasmic reticulum and TGH
The ER is closely linked to lipid droplets (LDs). LDs arise from ER: newly synthesized TG-rich vesicles with a surrounding phospholipid monolayer are considered to bud from the ER outer leaflet. 59 ER stress is part of the metabolic syndrome. 15 In functional proteomic studies, an ER lipase, TGH, contributed the most non-HSL hydrolase activity in adipocyte cytoplasmic and fat cake fractions. 60 is currently an active area of study. Up to 1.5% of Drosophila genes influence LD size and formation. 67 The LDS is composed of a phospholipid monolayer, 59 and has a distinct proteome 68 composed of lipase-related, cytoskeletal and other proteins. Prominent among these are members of the PAT family, including perilipin, the most abundant phosphoprotein in mature adipocytes and a master regulator of lipolysis on large LDs. Perilipin interacts directly with CGI-58 and indirectly controls the access of HSL to TGs. Other PAT family members are adipocyte differentiation-related protein, found on smaller droplets in non-adipose tissues, and OXPAT, a protein in lipolytically active cells with rapid FA oxidation. 69 Decreased lipolysis will increase LD volume, resulting in hypertrophied adipocytes and altered cell physiology, including the production of less adiponectin but more leptin than normal and in the increase in basal FA release in rough proportion to the increase in the LDS area. Mean adipocyte volume more than doubles in the first 12 months of life. 58 Assuming that adipocytes are spherical, there is a 30-fold difference between the volume of cells with diameters of 50 mm, which are frequent in children, and those with a diameter of 150 mm, which occur in obese individuals.
Recycling
Lipolysis is not a simple linear pathway (that is, TG-3FA þ glycerol). 21 Continual recycling occurs. In rats, 50% of FA cleaved from TGs reincorporate to TGs rather than exit the cell. 70 Recycling is a critical element in net FA release.
Furthermore, each step of TG synthesis can be mediated by any of up to six isozymes. 21, 71 The reason for this high redundancy is unclear, although it provides material for tissue specificity and refined, specific responses to given physiological conditions.
Conclusions
Similar to the other components of obesity and energy homeostasis, the apparently simple processes of FA release from adipocytes and of TG storage in WAT are in fact very complicated. In general, the symposium emphasized that the biological underpinnings of childhood obesity are multiple. Study of these factors is revealing new concepts that are important for understanding, preventing and treating childhood obesity and other disorders of energy homeostasis.
